Uneingeschränkter Zugang

Evaluation of the JAK2V617F mutational burden in patients with philadelphia chromosome negative myeloproliferative neoplasms: A single-center experience


Zitieren

M Popova-Labachevska
University Clinic of Hematology, UKIM-Faculty of Medicine, University “Ss Cyril and Methodius,”Skopje, RN Macedonia
I Panovska-Stavridis
University Clinic of Hematology, UKIM-Faculty of Medicine, University “Ss Cyril and Methodius,”Skopje, RN Macedonia
A Eftimov
Center for Biomolecular Pharmaceutical Analyses, UKIM-Faculty of Pharmacy, University “Ss Cyril and Methodius,”Skopje, RN Macedonia
Nestorovska A Kapedanovska
Center for Biomolecular Pharmaceutical Analyses, UKIM-Faculty of Pharmacy, University “Ss Cyril and Methodius,”Skopje, RN Macedonia
L Cevreska
University Clinic of Hematology, UKIM-Faculty of Medicine, University “Ss Cyril and Methodius,”Skopje, RN Macedonia
M Ivanovski
University Clinic of Hematology, UKIM-Faculty of Medicine, University “Ss Cyril and Methodius,”Skopje, RN Macedonia
N Ridova
University Clinic of Hematology, UKIM-Faculty of Medicine, University “Ss Cyril and Methodius,”Skopje, RN Macedonia
S Trajkova
University Clinic of Hematology, UKIM-Faculty of Medicine, University “Ss Cyril and Methodius,”Skopje, RN Macedonia
AJ Dimovski
Center for Biomolecular Pharmaceutical Analyses, UKIM-Faculty of Pharmacy, University “Ss Cyril and Methodius,”Skopje, RN Macedonia
eISSN:
1311-0160
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
2 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Vorklinische Medizin, Grundlagenmedizin, andere